Scarica l'app Stockscreener
3.38
0.29%
-0.01
Precedente Chiudi:
$3.39
Aprire:
$3.4
Volume 24 ore:
1.23M
Relative Volume:
1.05
Capitalizzazione di mercato:
$1.25B
Reddito:
$159.54M
Utile/perdita netta:
$5.06M
Rapporto P/E:
-768.18
EPS:
-0.0044
Flusso di cassa netto:
$26.19M
1 W Prestazione:
+2.11%
1M Prestazione:
+18.60%
6M Prestazione:
+26.59%
1 anno Prestazione:
+30.00%
Intervallo 1D:
$3.31
$3.4209
Intervallo di 1 settimana:
$3.27
$3.6077
Portata 52W:
$2.28
$3.6077
Cronos Group Inc Stock (CRON) Company Profile
Nome
Cronos Group Inc
Settore
Telefono
(416) 504-0004
Indirizzo
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRON
Cronos Group Inc
|
3.38 | 1.19B | 159.54M | 5.06M | 26.19M | -0.0044 |
TAK
Takeda Pharmaceutical Co Adr
|
18.03 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.11 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.44 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.34 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
515.46 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-28 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | Aggiornamento | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-27 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-11-18 | Ripresa | BofA Securities | Underperform |
| 2021-04-28 | Ripresa | BofA Securities | Underperform |
| 2021-02-22 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | Aggiornamento | MKM Partners | Neutral → Buy |
| 2020-03-03 | Downgrade | Stifel | Buy → Hold |
| 2019-10-18 | Aggiornamento | Stifel | Hold → Buy |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-09-05 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-09 | Aggiornamento | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | Iniziato | Consumer Edge Research | Equal Weight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | Iniziato | BofA/Merrill | Underperform |
| 2019-03-27 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | Iniziato | Jefferies | Underperform |
| 2019-01-18 | Iniziato | CIBC | Sector Outperform |
Mostra tutto
Cronos Group Inc Borsa (CRON) Ultime notizie
Cronos Group Inc. stock rises Friday, outperforms market - MarketWatch
Cronos Group (NASDAQ:CRON) Faces New Policy Challenges - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) Facing a Fresh Liquidity Test? - Kalkine Media
Cronos (CRON) Market: Moves 2.13% Lower to $3.22 on the Day; Level Watch: the Current Price Sits Inside the Supplied Technical Range in Latest TradingWyckoff Upthrust - Vinanet
Cronos Group Inc. stock falls Thursday, underperforms market - MarketWatch
Cronos Group (NASDAQ: CRON): What Could Shape Its Next Phase? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) in Focus Today? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) on Watch as Cannabis Policy Evolves? - Kalkine Media
Could Cronos Group (TSX:CRON) Rebuild Its Market Story? - Kalkine Media
Cronos Group Inc. stock rises Wednesday, outperforms market - MarketWatch
Cronos Group (TSX:CRON) Following Profit Return, Is The Fair Value Case Still Intact? - simplywall.st
Why Is Cronos Group (NASDAQ:CRON) Drawing a New Wave of Attention? - Kalkine Media
EBIT per share of Cronos Group Inc – HAM:7CI - TradingView
Diluted shares outstanding of Cronos Group Inc – HAM:7CI - TradingView
Mercury Systems Posts Mixed Q4 Results, Joins WhiteFiber And Other Big Stocks Moving Lower In Wednesday’s - Benzinga
Cronos Group Surges as Record Q2 Fuels Cannabis Turnaround Story - kalkine.ca
Why Keysight Shares Are Trading Higher By 3%; Here Are 20 Stocks Moving Premarket - Benzinga
Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch
Surging Earnings Estimates Signal Upside for Cronos (CRON) Stock - Yahoo Finance
Cronos Group Inc. (NASDAQ:CRON) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
What Is Driving Interest in Cronos Group (NASDAQ:CRON)? - Kalkine Media
Cronos Group (CRON) Institutional Ownership 2026 $CRON - MarketBeat
Can Cronos Group (NASDAQ:CRON) Sustain Its Record Revenue Streak? - Kalkine Media
Cronos Group (NASDAQ:CRON) Stock Rating Lowered by Wall Street Zen - MarketBeat
Trulieve Cannabis (NYSE:TRUL) Climbs Into Spotlight As Sector Sentiment Shifts - Kalkine Media
Why Cronos Group Inc. (NASDAQ:CRON) Is Back In Focus? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) In Focus as Cannabis Rules Evolve Worth Watching? - Kalkine Media
Cronos (CRON) Q2 2026 Earnings Call Transcript - The Globe and Mail
Could Cronos Group (TSX:CRON) Be Canada’s Next Growth Stock? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) on Watch as Dow Trades Mixed? - Kalkine Media
Cronos Group (NASDAQ:CRON) the Cannabis Name Drawing Notice This Season - Kalkine Media
Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch
Why Trump Media Stock Just Sank 9.4% - The Motley Fool
Why Cronos Group (NASDAQ:CRON) Keeps Building Global Cannabis Brand Reach? - Kalkine Media
Cronos Group Inc. (NASDAQ:CRON): Can Stronger Operations Support Growth? - Kalkine Media
Cronos Group (NASDAQ:CRON): Can Brand Demand Strengthen? - Kalkine Media
TSX Value Stock Estimates Featuring Cronos Group And 2 More - webull.com
Cronos Group (TSX:CRON) Is Up 6.4% After Swinging Back To Profit And Beating Q2 Expectations - webull.com
Cronos Group Inc. 8-K/A Filing Confirms Annual Say-on-Pay Votes for Shareholders - Minichart
Deferred share unit grant for Cronos Group Inc. (CRON) director Garnick - Stock Titan
Director grant at Cronos Group Inc. (CRON) adds deferred share units - Stock Titan
Cronos Group Inc. (CRON) director receives deferred share unit award - Stock Titan
Cronos Group (NASDAQ:CRON) Brand Growth & Market Expansion Update - Kalkine Media
Cronos Group Inc (CRON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts (NASDAQ:CRON) - Seeking Alpha
Why Cronos Group (NASDAQ:CRON) Is The Talk Of The Cannabis Sector Today? - Kalkine Media
Cronos Group expands in Europe with strong Q2 g... - Pluang
Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A - Seeking Alpha
Cronos Group Stock Surges 13.68% as Cannabis Market Optimism and International Growth Spark Investor Interest - kalkine.ca
Why Has Cronos Group (TSX:CRON) Regained Market Spotlight Again? - Kalkine Media
CRON SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fil - GuruFocus
Cronos Group Inc Azioni (CRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cronos Group Inc Azioni (CRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wagner Adam | See remarks |
May 12 '26 |
Option Exercise |
0.00 |
10,367 |
0 |
103,987 |
| Buggy Shannon | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
20,622 |
0 |
187,501 |
| Kenost Jared Matthew | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
9,412 |
0 |
46,675 |
| Weigensberg Arye | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
3,118 |
0 |
211,555 |
| Wagner Adam | See remarks |
May 10 '26 |
Option Exercise |
0.00 |
20,470 |
0 |
93,620 |
| Kenost Jared Matthew | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
12,649 |
0 |
39,141 |
| Shlimak Anna | See Remarks |
Mar 19 '26 |
Option Exercise |
0.00 |
28,429 |
0 |
368,362 |
| Doucet Terrence Gregory Joseph | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
23,897 |
0 |
117,466 |
| Weigensberg Arye | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
24,236 |
0 |
208,437 |
| GORENSTEIN MICHAEL RYAN | See remarks below |
Mar 15 '26 |
Option Exercise |
0.00 |
324,540 |
0 |
13,340,723 |
3.05%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):